Toggle navigation
Home
Search
Services
Blog
Contact
About
AIDS/Malignancies Consortium
Freter, Carl E.
Georgetown University, Washington, DC, United States
Search 8 grants from Carl Freter
Search grants from Georgetown University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Postnatal Actions of Maternal Obesity on Neonatal Metabolic Health
Biophysical Studies on Transmembrane Peptide of Alpha Factor Receptor
Asthma & Allergic Disease Center for Immunodermatology
Effects of IL-1 on Glucocorticoid Function
Consumer Development Human Resource Project
Recently added grants:
Nucleolin Regulation of miRome by Shear Stress
Non-platelet P2Y Receptor in Vascular Inflammation and Thrombogenesis
Variant Hemoglobin and Cardiorespiratory Regulation in Humans
The Role of Lung-Resident Memory Th2 cells in Asthma
Analysis of Mural Cell Ontogeny and Gene Function During Vascular Development
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01CA070078-02
Application #
2009481
Study Section
Special Emphasis Panel (SRC (09))
Project Start
1995-09-30
Project End
1999-07-31
Budget Start
1996-08-01
Budget End
1997-07-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Georgetown University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Related projects
NIH 1997
U01 CA
AIDS/Malignancies Consortium
Freter, Carl E. / Georgetown University
NIH 1996
U01 CA
AIDS/Malignancies Consortium
Freter, Carl E. / Georgetown University
NIH 1995
U01 CA
AIDS/Malignancies Consortium
Freter, Carl E. / Georgetown University
Publications
Ratner, L; Lee, J; Tang, S et al.
(2001)
Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy.
J Clin Oncol 19:2171-8
Comments
Be the first to comment on Carl Freter's grant